Literature DB >> 15730401

IgG subclass distribution of the rheumatoid arthritis-specific autoantibodies to citrullinated fibrin.

S Chapuy-Regaud1, L Nogueira, C Clavel, M Sebbag, C Vincent, G Serre.   

Abstract

In the rheumatoid synovium, deiminated ('citrullinated') forms of fibrin are the major targets of IgG autoantibodies to citrullinated proteins (ACPA), the most specific serological markers of rheumatoid arthritis (RA). To further the characterization of ACPA, we determined their subclass distribution. From a previously validated highly sensitive and specific enzyme-linked immunosorbent assay (ELISA) onto in vitro deiminated human fibrinogen - antihuman fibrin(ogen) autoantibodies (AhFibA)-ELISA - we derived and calibrated four ELISAs, using monoclonal antibodies to each of the four IgG subclasses, to determine the proportions of AhFibA subclasses in the sera. A series of 186 serum samples from RA patients was analysed. All AhFibA-positive sera contained IgG1-AhFibA, which reached the highest titres and accounted for more than 80% of AhFibA in three-quarters of the sera. One or two other subclasses were associated with IgG1 in 39% of the sera, IgG4-AhFibA being observed much more frequently and at higher titres than IgG3- or IgG2-AhFibA. IgG1 alone or IgG(1 + 4)-AhFibA were the AhFibA subclass profiles found in more than 80% of patients. AhFibA are mainly IgG1 and, to a lesser extent, IgG4. Such IgG subclass profiles may influence the effector phases of the immunological conflict between ACPA and deiminated fibrin that takes place specifically in the rheumatoid synovium and therefore may play a critical role in the self-maintenance of rheumatoid inflammation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15730401      PMCID: PMC1809305          DOI: 10.1111/j.1365-2249.2004.02708.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  54 in total

Review 1.  Human receptors for immunoglobulin G: key elements in the pathogenesis of rheumatic disease.

Authors:  J E Salmon; L Pricop
Journal:  Arthritis Rheum       Date:  2001-04

2.  The major synovial targets of the rheumatoid arthritis-specific antifilaggrin autoantibodies are deiminated forms of the alpha- and beta-chains of fibrin.

Authors:  C Masson-Bessière; M Sebbag; E Girbal-Neuhauser; L Nogueira; C Vincent; T Senshu; G Serre
Journal:  J Immunol       Date:  2001-03-15       Impact factor: 5.422

3.  Autoantibodies to the extracellular and intracellular domain of bullous pemphigoid 180, the putative key autoantigen in bullous pemphigoid, belong predominantly to the IgG1 and IgG4 subclasses.

Authors:  E Laffitte; M Skaria; F Jaunin; K Tamm; J H Saurat; B Favre; L Borradori
Journal:  Br J Dermatol       Date:  2001-04       Impact factor: 9.302

4.  Immunosuppressant effect of gold on IgG subclasses and IgE; evidence for sparing of Th2 responses.

Authors:  P D Kiely; M R Helbert; J Miles; D B Oliveira
Journal:  Clin Exp Immunol       Date:  2000-05       Impact factor: 4.330

Review 5.  Inflammation in autoimmunity: receptors for IgG revisited.

Authors:  H M Dijstelbloem; J G van de Winkel; C G Kallenberg
Journal:  Trends Immunol       Date:  2001-09       Impact factor: 16.687

6.  The distribution of pemphigus vulgaris-IgG subclasses and their reactivity with desmoglein 3 and 1 in pemphigus patients and their first-degree relatives.

Authors:  D Kricheli; M David; M Frusic-Zlotkin; D Goldsmith; M Rabinov; J Sulkes; Y Milner
Journal:  Br J Dermatol       Date:  2000-08       Impact factor: 9.302

7.  Antifilaggrin antibodies in early rheumatoid arthritis may predict radiological progression.

Authors:  K Forslind; C Vincent; G Serre; B Svensson
Journal:  Scand J Rheumatol       Date:  2001       Impact factor: 3.641

8.  Performance of two ELISAs for antifilaggrin autoantibodies, using either affinity purified or deiminated recombinant human filaggrin, in the diagnosis of rheumatoid arthritis.

Authors:  L Nogueira; M Sebbag; C Vincent; M Arnaud; B Fournié; A Cantagrel; M Jolivet; G Serre
Journal:  Ann Rheum Dis       Date:  2001-09       Impact factor: 19.103

9.  Association of autoantibodies to filaggrin with an active disease in early rheumatoid arthritis.

Authors:  L Paimela; T Palosuo; K Aho; M Lukka; P Kurki; M Leirisalo-Repo; R von Essen
Journal:  Ann Rheum Dis       Date:  2001-01       Impact factor: 19.103

10.  Role of Fc receptor gamma chain in inflammation and cartilage damage during experimental antigen-induced arthritis.

Authors:  P L van Lent; A J van Vuuren; A B Blom; A E Holthuysen; L B van de Putte; J G van de Winkel; W B van den Berg
Journal:  Arthritis Rheum       Date:  2000-04
View more
  32 in total

1.  Correlation of Lyme Disease-Associated IgG4 Autoantibodies With Synovial Pathology in Antibiotic-Refractory Lyme Arthritis.

Authors:  Katherine B Sulka; Klemen Strle; Jameson T Crowley; Robert B Lochhead; Robert Anthony; Allen C Steere
Journal:  Arthritis Rheumatol       Date:  2018-09-24       Impact factor: 10.995

Review 2.  The clinical significance of posttranslational modification of autoantigens.

Authors:  Maria G Zavala-Cerna; Erika A Martínez-García; Olivia Torres-Bugarín; Benjamín Rubio-Jurado; Carlos Riebeling; Arnulfo Nava
Journal:  Clin Rev Allergy Immunol       Date:  2014-08       Impact factor: 8.667

Review 3.  Beyond citrullination: other post-translational protein modifications in rheumatoid arthritis.

Authors:  Leendert A Trouw; Theo Rispens; Rene E M Toes
Journal:  Nat Rev Rheumatol       Date:  2017-03-09       Impact factor: 20.543

4.  Errors in data interpretation from genetic variation of human analytes.

Authors:  Heather L Howie; Meghan Delaney; Xiaohong Wang; Lay See Er; Linda Kapp; Jenna N Lebedev; James C Zimring
Journal:  JCI Insight       Date:  2017-07-06

5.  Immunoglobulin (Ig)G1 and IgG4 anti-cyclic citrullinated peptide (CCP) associate with shared epitope, whereas IgG2 anti-CCP associates with smoking in patients with recent-onset rheumatoid arthritis (the Swedish TIRA project).

Authors:  K Martinsson; A Johansson; A Kastbom; T Skogh
Journal:  Clin Exp Immunol       Date:  2017-01-10       Impact factor: 4.330

6.  In ACPA-positive RA patients, antibodies to EBNA35-58Cit, a citrullinated peptide from the Epstein-Barr nuclear antigen-1, strongly cross-react with the peptide β60-74Cit which bears the immunodominant epitope of citrullinated fibrin.

Authors:  M Cornillet; E Verrouil; A Cantagrel; G Serre; L Nogueira
Journal:  Immunol Res       Date:  2015-02       Impact factor: 2.829

7.  Gilt required for RTL550-CYS-MOG to treat experimental autoimmune encephalomyelitis.

Authors:  Gregory G Burrows; Roberto Meza-Romero; Jianya Huan; Sushmita Sinha; Jeffrey L Mooney; Arthur A Vandenbark; Halina Offner
Journal:  Metab Brain Dis       Date:  2012-03-07       Impact factor: 3.584

8.  In the rat, citrullinated autologous fibrinogen is immunogenic but the induced autoimmune response is not arthritogenic.

Authors:  V Duplan; C Foulquier; C Clavel; R Al Badine; G Serre; A Saoudi; M Sebbag
Journal:  Clin Exp Immunol       Date:  2006-09       Impact factor: 4.330

9.  Label-free detection of immune complexes with myeloid cells.

Authors:  Z Szittner; A E H Bentlage; P Rovero; P Migliorini; V Lóránd; J Prechl; G Vidarsson
Journal:  Clin Exp Immunol       Date:  2016-05-12       Impact factor: 4.330

10.  Elevation of serum IgG subclass concentration in patients with rheumatoid arthritis.

Authors:  Guigao Lin; Jinming Li
Journal:  Rheumatol Int       Date:  2010-01-06       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.